Achieve Life Sciences, Inc.
ACHV
Revenue
0.00
0.000.00%
12 Months ChangeAssets
64.79M
▼-5.24M▼-7.48%
3 Months ChangeLiabilities
22.51M
▲1.93M▲9.40%
3 Months ChangeFree Cash Flow
-4.46M
▲480.00k▲9.71%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-27
Form 8-K
ID: 0000950170-24-110066
2024-08-26
Form 8-K
ID: 0001193125-24-207129
2024-08-13
Form 10-Q
ID: 0000950170-24-096193
2024-08-13
Form 8-K
ID: 0000950170-24-096171
2024-07-29
Form 8-K
ID: 0000950170-24-087118
2024-06-27
Form 8-K
ID: 0000950170-24-078445
2024-06-06
Form 8-K
ID: 0000950170-24-069973
2024-05-09
Form 10-Q
ID: 0000950170-24-056929
2024-05-09
Form 8-K
ID: 0000950170-24-056876
2024-03-28
Form 8-K
ID: 0000950170-24-038030